Pay in 4 interest-free payments of $5.77 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Chng ti t ho l a ch uy tn chuyn cung cp cc sn phm chm sc sc khe v lm p cht lng cao
As a synthetic analog of its endogenous exendin-4, compared with exendin-4, LIXI deleted one proline and added six lysine residues, which increased its binding affinity with the GLP-1R by four times and increased its circulating half-life (58, 59)
If denied, the most common reasons are: Insufficient metformin trial duration (submitted 60 days instead of required 90 days) Missing A1C lab result from past 90 days A1C below 7.0% (Ambetter considers diabetes "controlled" and does not approve intensification) Diagnosis code submitted as E11.9 (unspecified diabetes) instead of more specific code A study by the American Diabetes Association (Gabbay et al., Diabetes Care 2024) found that prior authorization denials for GLP-1 receptor agonists were overturned on appeal in 71% of cases when resubmitted with complete documentation
Fat Loss : Some peptides promote fat breakdown by helping the body utilize stored fat for energy
As a single, well-characterised compound, it has a defined molecular structure, molecular weight, and an established position in copper-peptide research literature, where it has been studied for its metal-binding and copper-chelating properties
